PeptiGrowth Inc.

お知らせ

Innovative Functional Peptides Successfully Co-Developed with Orizuru Therapeutics Inc.

2025/01/29

We succeeded to co-develop chemically synthesized peptide as an alternative to specific recombinant growth factors used in the manufacturing of regenerative medicine products with Orizuru Therapeutics, Inc. The developed peptide was confirmed to bind to cellular receptors in a manner similar to the respective recombinant growth factor, inducing phosphorylation and signaling within the cells, thereby triggering differentiation and proliferation of iPSCs.

For more details, please refer to the press release.
Innovative Functional Peptides Successfully Co-Developed as Alternatives to Growth Factors Used in the Manufacturing of Regenerative Medicine Products